| Zachary David Reardon, MD | |
|
168 Mobile Infirmary Blvd, Mobile, AL 36607-3510 | |
| (251) 433-1895 | |
| Not Available |
| Full Name | Zachary David Reardon |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 13 Years |
| Location | 168 Mobile Infirmary Blvd, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073804209 | NPI | - | NPPES |
| 185075 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 35016 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Thomas Hospital | Fairhope, AL | Hospital |
| Singing River Health System | Pascagoula, MS | Hospital |
| Grove Hill Memorial Hospital | Grove hill, AL | Hospital |
| Springhill Medical Center | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Associates Of Mobile, P.a. | 3870497951 | 49 |
News Archive
Patients whose cancer has spread to the brain can avoid typical hair loss (alopecia) when treated with newer radiation techniques, thereby improving their quality of life while still controlling their cancer, according to a study presented October 16, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Sifting through the pages of newspapers, most people reading stories about autism would think scientists are primarily grappling with understanding how environmental factors, such as childhood vaccines, might contribute to the condition.
The overall incidence in 2012-2013 was relatively low of a serious, highly drug-resistant group of bacteria (Carbapenem-resistant Enterobacteriaceae [CRE]) that are an important cause for health-care associated infections, according to a study published online by JAMA. Most CRE cases were associated with prior hospitalizations and discharge to long-term care settings.
Single-walled carbon nanotubes (SWCNTs) can kill bacteria like the common pathogen E. coli by severely damaging their cell walls, according to a recent report from Yale researchers in the American Chemical Society (ACS) journal Langmuir.
Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung function and the safety of a range of doses in patients with moderate to severe chronic obstructive pulmonary disease.
› Verified 3 days ago
| Entity Name | Urology Associates Of Mobile, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194828368 PECOS PAC ID: 3870497951 Enrollment ID: O20031120000743 |
News Archive
Patients whose cancer has spread to the brain can avoid typical hair loss (alopecia) when treated with newer radiation techniques, thereby improving their quality of life while still controlling their cancer, according to a study presented October 16, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Sifting through the pages of newspapers, most people reading stories about autism would think scientists are primarily grappling with understanding how environmental factors, such as childhood vaccines, might contribute to the condition.
The overall incidence in 2012-2013 was relatively low of a serious, highly drug-resistant group of bacteria (Carbapenem-resistant Enterobacteriaceae [CRE]) that are an important cause for health-care associated infections, according to a study published online by JAMA. Most CRE cases were associated with prior hospitalizations and discharge to long-term care settings.
Single-walled carbon nanotubes (SWCNTs) can kill bacteria like the common pathogen E. coli by severely damaging their cell walls, according to a recent report from Yale researchers in the American Chemical Society (ACS) journal Langmuir.
Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung function and the safety of a range of doses in patients with moderate to severe chronic obstructive pulmonary disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zachary David Reardon, MD 4752 Old Shell Rd, Mobile, AL 36608-2333 Ph: (239) 851-2271 | Zachary David Reardon, MD 168 Mobile Infirmary Blvd, Mobile, AL 36607-3510 Ph: (251) 433-1895 |
News Archive
Patients whose cancer has spread to the brain can avoid typical hair loss (alopecia) when treated with newer radiation techniques, thereby improving their quality of life while still controlling their cancer, according to a study presented October 16, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Sifting through the pages of newspapers, most people reading stories about autism would think scientists are primarily grappling with understanding how environmental factors, such as childhood vaccines, might contribute to the condition.
The overall incidence in 2012-2013 was relatively low of a serious, highly drug-resistant group of bacteria (Carbapenem-resistant Enterobacteriaceae [CRE]) that are an important cause for health-care associated infections, according to a study published online by JAMA. Most CRE cases were associated with prior hospitalizations and discharge to long-term care settings.
Single-walled carbon nanotubes (SWCNTs) can kill bacteria like the common pathogen E. coli by severely damaging their cell walls, according to a recent report from Yale researchers in the American Chemical Society (ACS) journal Langmuir.
Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung function and the safety of a range of doses in patients with moderate to severe chronic obstructive pulmonary disease.
› Verified 3 days ago
Selden Harbour Stephens Iii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 168 Mobile Infirmary Blvd, Mobile, AL 36607 Phone: 251-433-1895 Fax: 251-433-1917 | |
Mariarita Salvitti Fermin, MD Urology Medicare: Medicare Enrolled Practice Location: 1601 Center St, Mobile, AL 36604 Phone: 251-410-5437 Fax: 251-410-5437 | |
Dr. Thomas W Coleman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd, Ste B111, Mobile, AL 36608 Phone: 251-378-3000 Fax: 251-378-3001 | |
Dino Nicholas Frangos, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 168 Mobile Infirmary Blvd, Mobile, AL 36607 Phone: 251-433-1895 Fax: 251-433-1917 | |
Guy Coleman Oswalt Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 168 Mobile Infirmary Blvd, Mobile, AL 36607 Phone: 251-433-1895 Fax: 251-433-1917 | |
Paul Anthony Scott Sr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 168 Mobile Infirmary Blvd, Mobile, AL 36607 Phone: 251-433-1895 Fax: 251-433-1917 |